UBS AM’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-99,360
| Closed | -$15.2M | – | 2797 |
|
|
2021
Q1 | $15.2M | Sell |
99,360
-2,992
| -3% | -$459K | 0.01% | 945 |
|
|
2020
Q4 | $12.8M | Buy |
102,352
+13,953
| +16% | +$1.75M | 0.01% | 966 |
|
|
2020
Q3 | $8.97M | Buy |
88,399
+6,672
| +8% | +$677K | ﹤0.01% | 971 |
|
|
2020
Q2 | $7.95M | Sell |
81,727
-662
| -0.8% | -$64.4K | ﹤0.01% | 977 |
|
|
2020
Q1 | $6.84M | Buy |
82,389
+7,649
| +10% | +$635K | ﹤0.01% | 965 |
|
|
2019
Q4 | $8.31M | Buy |
74,740
+4,507
| +6% | +$501K | 0.01% | 1007 |
|
|
2019
Q3 | $6.97M | Buy |
70,233
+6,958
| +11% | +$690K | ﹤0.01% | 1080 |
|
|
2019
Q2 | $6.27M | Buy |
63,275
+5,860
| +10% | +$581K | ﹤0.01% | 1115 |
|
|
2019
Q1 | $6.33M | Buy |
57,415
+12,279
| +27% | +$1.35M | ﹤0.01% | 1069 |
|
|
2018
Q4 | $4.15M | Buy |
45,136
+2,675
| +6% | +$246K | ﹤0.01% | 1153 |
|
|
2018
Q3 | $4.68M | Buy |
42,461
+4,112
| +11% | +$453K | ﹤0.01% | 1159 |
|
|
2018
Q2 | $3.58M | Buy |
38,349
+8,049
| +27% | +$751K | ﹤0.01% | 1275 |
|
|
2018
Q1 | $2.51M | Buy |
30,300
+2,270
| +8% | +$188K | ﹤0.01% | 1376 |
|
|
2017
Q4 | $2.55M | Buy |
28,030
+293
| +1% | +$26.7K | ﹤0.01% | 1327 |
|
|
2017
Q3 | $2.11M | Buy |
27,737
+5,679
| +26% | +$433K | ﹤0.01% | 1382 |
|
|
2017
Q2 | $1.65M | Buy |
22,058
+1,303
| +6% | +$97.7K | ﹤0.01% | 1433 |
|
|
2017
Q1 | $1.35M | Buy |
20,755
+7,999
| +63% | +$522K | ﹤0.01% | 1510 |
|
|
2016
Q4 | $703K | Sell |
12,756
-4,885
| -28% | -$269K | ﹤0.01% | 1700 |
|
|
2016
Q3 | $996K | Buy |
17,641
+4,407
| +33% | +$249K | ﹤0.01% | 1693 |
|
|
2016
Q2 | $553K | Buy |
13,234
+1,400
| +12% | +$58.5K | ﹤0.01% | 1912 |
|
|
2016
Q1 | $506K | Buy |
11,834
+4,540
| +62% | +$194K | ﹤0.01% | 1914 |
|
|
2015
Q4 | $330K | Hold |
7,294
| – | – | ﹤0.01% | 2296 |
|
|
2015
Q3 | $283K | Buy |
7,294
+494
| +7% | +$19.2K | ﹤0.01% | 2317 |
|
|
2015
Q2 | $247K | Buy |
+6,800
| New | +$247K | ﹤0.01% | 2484 |
|